Pharmacological principles of antibiotic prescription in the critically ill

被引:81
作者
Pinder, M
Bellomo, R
Lipman, J
机构
[1] Royal Brisbane Hosp, Dept Intens Care, Brisbane, Qld 4029, Australia
[2] Intens Care Unit, Perth, WA, Australia
[3] Austin & Repatriat Med Ctr, Melbourne, Vic, Australia
关键词
antibiotics; intensive care unit; haemofiltration; acute renal failure; pharmacokinetics; pharmacodynamics;
D O I
10.1177/0310057X0203000203
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The goal of antimicrobial prescription is to achieve effective drug concentrations. Standard antimicrobial (losing regimens are based on research performed often decades ago and for the most part with patients who were not critically, ill. More recent insights into antibiotic activity (e.g. the importance of high peak/MIC ratios for aminoglycosides and time above MIC for beta-lactam antibiotics), drug pharmacokinetics (e.g. increased volume of distribution and altered clearances) and the pathogenesis of sepsis (e.g. third space losses and altered creatinine clearances have made re-evaluation of dosing regimens necessary for the critically ill. The inflammatory, response associated with sepsis results in a rapid decrease in serum albumin levels, large fluid shifts and third space losses, initially, with a high cardiac output. In turn these changes result in increased creatinine clearance and increased renal drug clearance. Unless these effects are offset by ensuing renal and/or hepatic impairment, with subsequent drug accumulation, antibiotic levels may, be too low for optimal efficacy. The institution of continuous renal replacement therapy separately, affects antibiotic clearances, and therefore dosing, even further. This article reviews relevant literature and offers principles for more effective and appropriate antibiotic dosing in the critically, ill, based oil the pharmacokinetic and pharmacodynamic principles of the main antibiotic groups (aminoglyosides, glycopeptides, beta-lactams, carbapenems and quinolones) and knowledge of the pathophysiology, of the inflammatory response syndrome. Finally, it also provides sonic guidance oil the basic principles of drug prescription for patients receiving continuous renal replacement therapy.
引用
收藏
页码:134 / 144
页数:11
相关论文
共 110 条
[71]   KILLING OF PSEUDOMONAS-AERUGINOSA DURING CONTINUOUS AND INTERMITTENT INFUSION OF CEFTAZIDIME IN AN IN-VITRO PHARMACOKINETIC MODEL [J].
MOUTON, JW ;
DENHOLLANDER, JG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :931-936
[72]   Comparative pharmacokinetics of the carbapenems - Clinical implications [J].
Mouton, JW ;
Touw, DJ ;
Horrevorts, AM ;
Vinks, AATMM .
CLINICAL PHARMACOKINETICS, 2000, 39 (03) :185-201
[73]   Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion [J].
Mouton, JW ;
Vinks, AATMM ;
Punt, NC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :733-738
[74]   Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia [J].
Nicolau, DP ;
McNabb, JC ;
Lacy, MK ;
Li, J ;
Quintiliani, R ;
Nightingale, CH .
CLINICAL DRUG INVESTIGATION, 1999, 18 (02) :133-139
[75]   EXPERIENCE WITH A ONCE-DAILY AMINOGLYCOSIDE PROGRAM ADMINISTERED TO 2,184 ADULT PATIENTS [J].
NICOLAU, DP ;
FREEMAN, CD ;
BELLIVEAU, PP ;
NIGHTINGALE, CH ;
ROSS, JW ;
QUINTILIANI, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :650-655
[76]   Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia [J].
Nicolau, DP ;
Lacy, MK ;
McNabb, JC ;
Quintiliani, R ;
Nightingale, CH .
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (01) :45-49
[77]   DOSE-RANGING PHARMACOKINETIC STUDY OF CIPROFLOXACIN AFTER 200-MG, 300-MG AND 400-MG INTRAVENOUS DOSES [J].
NIX, DE ;
SPIVEY, JM ;
NORMAN, A ;
SCHENTAG, JJ .
ANNALS OF PHARMACOTHERAPY, 1992, 26 (01) :8-10
[78]  
NIX DE, 1993, DOSING CONSIDERATION
[79]  
NUYTINCK HKS, 1988, ARCH SURG-CHICAGO, V123, P1519
[80]   INFLUENCE OF DOSAGE REGIMEN ON EXPERIMENTAL TOBRAMYCIN NEPHROTOXICITY - A BIOCHEMICAL APPROACH [J].
OLIER, B ;
VIOTTE, G ;
MORIN, JP ;
FILLASTRE, JP .
CHEMOTHERAPY, 1983, 29 (06) :385-394